We are proud to highlight the contributions of female scientists in our team and embrace the milestones reached by women in STEM all over the world.

Portrait® Flex takes circulating tumor cell (CTC) analysis to the next level.

ANGLE’s Portrait® PD-L1 testing solution is a novel approach for evaluating the expression of PD-L1 on circulating tumour cells (CTCs).

From Jan 30-Feb 1 at The Colonnade in Boston!

Complementary insights from a single blood sample utilising the Parsortix® system.

Circulating tumor cells (CTCs) harvested using the Parsortix® system, reveal a gene expression profile associated with development and progression of brain metastasis in melanoma.

Molecular profiling of CTC-DNA, from CTCs enriched by Parsortix® technology, alongside ctDNA from the same blood sample has the potential to revolutionize cancer treatment.

Where we will be discussing how liquid biopsy and the illuminating power of circulating tumor cells (CTCs) could revolutionize the treatment of breast cancer.

This innovative new product provides advanced immunofluorescent staining of circulating tumour cells (CTCs) enriched from blood processed by Parsortix® technology.

Our team decided to have a fun head-to-head bake-off competition and raised a wonderful £53 for the cause!